Literature DB >> 6197312

Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.

J M Hughes, J P Seale, D M Temple.   

Abstract

The inhibitory effects of fenoterol, a beta 2-adrenoceptor agonist, on the release of SRS-A leukotrienes and histamine from chopped human lung tissue were measured and selective beta-adrenoceptor antagonists used to investigate the nature of the receptors involved. Fenoterol 0.01-1.0 microM inhibited the antigen-induced release of SRS-A and histamine, but not the release induced by the calcium ionophore A23187. Propranolol 0.1 and 1.0 microM and butoxamine 10 and 100 microM significantly antagonized the effects of fenoterol 0.1 microM on SRS-A and histamine at concentrations which affect (beta 2-adrenoceptors, while atenolol 0.1 to 10 microM showed no antagonism at concentrations which affect beta 1-adrenoceptors. These results suggest that adrenoceptors in human lung which modulate the immunological release of SRS-A leukotrienes are of the beta 2-subtype as for histamine release.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197312     DOI: 10.1016/0014-2999(83)90640-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Ranitidine does not potentiate mediator release from human lung in vitro.

Authors:  J M Hughes; J P Seale; D M Temple
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

Review 2.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

3.  Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats.

Authors:  W Zhang; L Guo; J A Nadel; D Papahadjopoulos
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

4.  Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties.

Authors:  N Frossard; J C Frankhuyzen-Sierevogel; M Binck; J Noordhoek; Y Landry
Journal:  Agents Actions       Date:  1985-04

5.  Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotriene and histamine from human lung fragments.

Authors:  F E Napier; M A Shearer; D M Temple
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

6.  The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.

Authors:  M Linden
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

7.  The ability of salbutamol and theophylline to suppress immediate allergic conjunctivitis in the guinea pig.

Authors:  P Gautheron; M F Sugrue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

8.  Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways.

Authors:  I Gorenne; C Labat; X Norel; V De Montpreville; M C Guillet; I Cavero; C Brink
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

Review 9.  Pharmacological treatment of chronic obstructive pulmonary disease.

Authors:  Paolo Montuschi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Association of beta 2-adrenergic receptor polymorphism with the phenotype of aspirin-intolerant acute urticaria.

Authors:  Hyoun-Ah Kim; Young-Min Ye; Seung-Hyun Kim; Gyu-Young Hur; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.